0RIS

Targovax Asa Notizie

Acquistare
Vendere
Le migliori offerte per accedere ai dati in tempo reale
Borsa di Londra
Sottoscrizione Mensile
per soli
22,17 €
Book Borsa di Londra
Sottoscrizione Mensile
per soli
59,13 €
World Guru
Sottoscrizione Mensile
per soli
126,50 €
Prezzi IVA esclusa
Nome Azione Simbolo Borsa Mercato Tipo ISIN Descrizione
Targovax Asa 0RIS Londra Azione Ordinaria NO0010689326 TARGOVAX ORD SHS
  Variazione Variazione % Quotazione Attuale Min Max Apertura Chiusura Ora
0,00 0,0% 15,98 0,00 0,00 0,00 15,98 02:00:00
quotazione »

Ultime notizie

Data Ora Fonte Titolo
22/6/202007:19PRNUSTargovax's ONCOS-102 Mesothelioma 12-month Data Powerfully..
04/6/202008:19PRNUSTargovax Enters Collaboration With Leidos to add Checkpoint..
04/6/202008:16PRNUSTargovax Enters Collaboration With Leidos to add Checkpoint..
14/5/202009:08PRNUSTargovax Announces That the ONCOS-102 and Durvalumab..
14/5/202009:04PRNUSTargovax Announces That the ONCOS-102 and Durvalumab..
06/5/202007:22PRNUSTargovax Announces That Abstract on Interim Phase I Clinical..
06/5/202007:20PRNUSTargovax Announces That Abstract on Interim Phase I Clinical..
04/5/202007:23PRNUSTargovax Releases Update for Mesothelioma Trial Combining..
04/5/202007:20PRNUSTargovax Releases Update for Mesothelioma Trial Combining..
30/4/202007:20PRNUSTargovax ASA Appoints Dr Victor Levitsky as Chief Scientific..
30/4/202007:14PRNUSTargovax ASA Appoints Dr Victor Levitsky as Chief Scientific..
22/4/202007:13PRNUSTargovax and Valo Therapeutics Enter Collaboration to..
22/4/202007:11PRNUSTargovax and Valo Therapeutics Enter Collaboration to..
03/4/202007:23PRNUSTargovax ASA Announces Proposed New Chairman of the Board
03/4/202007:21PRNUSTargovax ASA Announces Proposed New Chairman of the Board
11/3/202007:10PRNUSTargovax ASA: Fourth Quarter 2019 Results
11/3/202007:09PRNUSTargovax ASA: Fourth Quarter 2019 Results
03/3/202007:17PRNUSTargovax Announces Completed Enrollment in the ONCOS-102..
03/3/202007:14PRNUSTargovax Announces Completed Enrollment in the ONCOS-102..
21/1/202017:18PRNUSTargovax Announces Encouraging Data in Mesothelioma Study..
21/1/202017:16PRNUSTargovax Announces Encouraging Data in Mesothelioma Study..
08/1/202013:07PRNUSUpdated Press Release: Targovax and IOVaxis Therapeutics..
08/1/202013:04PRNUSUpdated Press Release: Targovax and IOVaxis Therapeutics..
11/11/201907:28PRNUSPresentation of ONCOS-102 Melanoma Data at SITC Annual..
11/11/201907:20PRNUSPresentation of ONCOS-102 Melanoma Data at SITC Annual..
07/11/201907:49PRNUSTargovax ASA: Third Quarter 2019 Results
07/11/201907:29PRNUSTargovax ASA: Third Quarter 2019 Results
09/10/201907:40PRNUSTargovax Selected for Oral Presentation at Society for..
09/10/201907:32PRNUSTargovax Selected for Oral Presentation at Society for..
08/7/201918:48PRNUSTargovax Announces Encouraging Results From Part 1 of the..
08/7/201918:39PRNUSTargovax Announces Encouraging Results From Part 1 of the..
Accedi alle altre notizie sul titolo »
La tua Cronologia
LSE
0RIS
Targovax A..
Registrati ora per visualizzare questi strumenti nella tua watchlist streaming.

Il Monitor ADVFN ti permette di visualizzare fino a 110 titoli ed è completamente gratuito.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

P: V: D:20200707 10:39:13